Aug 6, 2026 04:03PM

Jul 14, 2026 06:57AM

Jul 13, 2026 09:05AM

Jul 13, 2026 09:05AM

Feb 25, 2026 08:20AM

Feb 23, 2026 04:05PM

Oct 29, 2025 09:01AM FDA accepts BioMarin's application to expand PALYNZIQ to adolescents

Oct 29, 2025 09:00AM

Oct 28, 2025 09:23AM

Oct 28, 2025 08:43AM

Aug 26, 2025 06:35AM

Jul 15, 2025 06:15AM

Jun 25, 2025 10:03AM

Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'

Sep 21, 2023 10:00AM

Sep 15, 2023 09:29AM

Sep 15, 2023 09:29AM

Jun 22, 2023 08:00AM

Apr 26, 2023 04:03PM

Mar 14, 2023 08:00AM

Mar 7, 2023 04:08PM BioMarin Pharma (BMRN) Announces FDA Accepts sNDA to Expand Use of VOXZOGO for Injection to Treat Children with Achondroplasia Under the Age of 5

Mar 7, 2023 04:05PM

Mar 7, 2023 07:07AM

Mar 6, 2023 07:28PM

Feb 27, 2023 04:03PM

Jan 9, 2023 05:05AM

Jan 8, 2023 11:00AM

Jan 4, 2023 08:39AM BioMarin (BMRN) PT Raised to $200 at BofA Securities, Added to US 1 List

Nov 7, 2022 04:31PM

Nov 7, 2022 04:30PM

Oct 26, 2022 04:03PM

Oct 12, 2022 05:12PM

Oct 12, 2022 04:05PM

Oct 12, 2022 04:05PM

Feb 9, 2022 08:31AM BioMarin Pharma (BMRN) Sells Priority Review Voucher for $110 Million

Feb 9, 2022 08:31AM

Oct 28, 2021 06:20AM

Oct 27, 2021 04:05PM

Aug 27, 2021 09:51AM

Aug 27, 2021 09:02AM

Aug 27, 2021 09:01AM

Aug 24, 2021 07:20AM BioMarin Pharmaceutical Inc. (BMRN) Likely to Get EU Approval of Voxzogo in Next 10 Days, Opening a $4.4B Opportunity - Cowen

Jul 28, 2021 04:03PM

Jun 25, 2021 07:30AM

Jun 25, 2021 07:29AM

Jun 22, 2021 07:15AM

Apr 29, 2021 04:03PM

Apr 15, 2021 08:35AM

Apr 15, 2021 08:31AM BioMarin Announces New and Updated Data at 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting Demonstrating Commitment to Understanding Achondroplasia and P

Mar 20, 2021 11:15AM

15,661 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All